Abstract:Although alveolar macrophages (AMs) play important roles in preventing and eliminating pulmonary infections, little is known about their regulation in healthy animals. Since exposure to LPS often renders cells hyporesponsive to subsequent LPS exposures ("tolerant"), we tested the hypothesis that LPS produced in the intestine reaches the lungs and stimulates AMs, rendering them tolerant. We found that resting AMs were more likely to be tolerant in mice lacking acyloxyacyl hydrolase (AOAH), the host lipase that degrades and inactivates LPS; isolated Aoah -/- AMs were less responsive to LPS stimulation and less phagocytic than were Aoah +/+ AMs. Upon innate stimulation in the airways, Aoah -/- mice had reduced epithelium- and macrophage-derived chemokine/cytokine production. Aoah -/- mice also developed greater and more prolonged loss of body weight and higher bacterial burdens after pulmonary challenge with Pseudomonas aeruginosa than did wildtype mice. We also found that bloodborne or intrarectally-administered LPS desensitized ("tolerized") AMs while antimicrobial drug treatment that reduced intestinal commensal Gram-negative bacterial abundance largely restored the innate responsiveness of Aoah -/- AMs. Confirming the role of LPS stimulation, the absence of TLR4 prevented Aoah -/- AM tolerance. We conclude that commensal LPSs may stimulate and desensitize (tolerize) alveolar macrophages in a TLR4-dependent manner and compromise pulmonary immunity. By inactivating LPS in the intestine, AOAH promotes antibacterial host defenses in the lung. AOAH is the host lipase that degrades and inactivates Gram-negative bacterial lipopolysaccharides (LPSs). AOAH is required for recovery from LPS-induced macrophage tolerance. Expressed in the gut, AOAH inactivates microbiota-derived LPS. In this study we found that AOAH-deficient mice were less able to contain pulmonary Pseudomonas aeruginosa infection than were control wildtype mice. Alveolar macrophages (AMs) from Aoah -/- mice were hypo-responsive to innate stimulation and they had reduced phagocytic activity. In addition, Aoah -/- AMs had metabolic changes characteristic of tolerant macrophages as well as increased cell-surface expression of MHC II and co-stimulatory molecules, findings suggesting that they had been stimulated in situ . Treating Aoah -/- mice with p.o. neomycin normalized AMs' innate responsiveness while intrarectal LPS administration tolerized AMs. We conclude that AOAH regulates pulmonary mucosal immunity in part by inactivating LPS in the gut. This study sheds light on a previously unappreciated mechanism that regulates pulmonary immune defense via the gut-lung axis.

A host lipase prevents lipopolysaccharide-induced foam cell formation

A host enzyme reduces non-alcoholic fatty liver disease by inactivating intestinal lipopolysaccharide

Acyloxyacyl hydrolase promotes pulmonary defense by preventing alveolar macrophage tolerance

A highly conserved host lipase deacylates oxidized phospholipids and ameliorates acute lung injury in mice

Lipopolysaccharide Up-Regulates the Expression of Fcalpha/mu Receptor and Promotes the Binding of Oxidized Low-Density Lipoprotein and Its IgM Antibody Complex to Activated Human Macrophages.

Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARγ-LXRα-ABCA1-dependent pathway associated with apoE

Intracellular-free calcium dynamics and F-actin alteration in the formation of macrophage foam cells.

Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARgamma-LXRalpha-ABCA1-dependent pathway associated with apoE.

Apolipoprotein E-deficient lipoproteins induce foam cell formation by downregulation of lysosomal hydrolases in macrophages

A Host Lipase Detoxifies Bacterial Lipopolysaccharides in the Liver and Spleen

Macrophage KLF15 prevents foam cell formation and atherosclerosis via transcriptional suppression of OLR-1

Acyloxyacyl Hydrolase Promotes the Resolution of Lipopolysaccharide-Induced Acute Lung Injury

Inhibition of Toll-like Receptors Alters Macrophage Cholesterol Efflux and Foam Cell Formation

Macrophagic CD146 Promotes Foam Cell Formation and Retention During Atherosclerosis

Influence of Apolipoprotein A-I on Expression of Monocyte Chemoattractant Protein-1, Vascular Celladhesion Molecule-1 and ATP-binding Cassette Transporter A1 in Macrophage Derived Foam Cells

Oxldl/β2gpi/anti-Β2gpi Complex Induced Macrophage Differentiation to Foam Cell Involving TLR4/NF-kappa B Signal Transduction Pathway

Apolipoprotein E-deficient Lipoproteins Induce Foam Cell Formation by Downregulation of Lysosomal Hydrolases in Macrophages Published, JLR Papers in Press, August 25, 2007.

LRPPRC Inhibits Autophagy and Promotes Foam Cell Formation in Atherosclerosis

Cholesterol Acceptors Regulate the Lipidome of Macrophage Foam Cells

Terpene Lactucopicrin Limits Macrophage Foam Cell Formation by a Reduction of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Lipid Rafts

Elevated MicroRNA-155 Targets HBP1 to Promote the Formation of Macrophage-Derived Foam Cell and This Can Be Effectively Suppressed by YY1/HDACs Complex